JP2019214620A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019214620A5 JP2019214620A5 JP2019171346A JP2019171346A JP2019214620A5 JP 2019214620 A5 JP2019214620 A5 JP 2019214620A5 JP 2019171346 A JP2019171346 A JP 2019171346A JP 2019171346 A JP2019171346 A JP 2019171346A JP 2019214620 A5 JP2019214620 A5 JP 2019214620A5
- Authority
- JP
- Japan
- Prior art keywords
- pge
- hsc
- cellular
- transplant
- cellular transplant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001413 cellular effect Effects 0.000 claims 10
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 238000002054 transplantation Methods 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 3
- 239000000018 receptor agonist Substances 0.000 claims 3
- 229940044601 receptor agonist Drugs 0.000 claims 3
- QAOBBBBDJSWHMU-WMBBNPMCSA-N 16,16-dimethylprostaglandin E2 Chemical compound CCCCC(C)(C)[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O QAOBBBBDJSWHMU-WMBBNPMCSA-N 0.000 claims 2
- 238000010322 bone marrow transplantation Methods 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 238000011476 stem cell transplantation Methods 0.000 claims 2
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 238000002512 chemotherapy Methods 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 210000004700 fetal blood Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 210000005259 peripheral blood Anatomy 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 125000006239 protecting group Chemical group 0.000 claims 1
- 238000001959 radiotherapy Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021170835A JP2022025091A (ja) | 2006-03-24 | 2021-10-19 | 造血性幹細胞の増殖を調節する方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78596806P | 2006-03-24 | 2006-03-24 | |
| US60/785,968 | 2006-03-24 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019027038A Division JP6797222B2 (ja) | 2006-03-24 | 2019-02-19 | 造血性幹細胞の増殖を調節する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021170835A Division JP2022025091A (ja) | 2006-03-24 | 2021-10-19 | 造血性幹細胞の増殖を調節する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019214620A JP2019214620A (ja) | 2019-12-19 |
| JP2019214620A5 true JP2019214620A5 (enExample) | 2020-11-12 |
Family
ID=38526581
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501606A Active JP5247675B2 (ja) | 2006-03-24 | 2007-03-26 | 造血性幹細胞の増殖を調節する方法 |
| JP2013046473A Expired - Fee Related JP6041711B2 (ja) | 2006-03-24 | 2013-03-08 | 造血性幹細胞の増殖を調節する方法 |
| JP2015147317A Active JP6208719B2 (ja) | 2006-03-24 | 2015-07-27 | 造血性幹細胞の増殖を調節する方法 |
| JP2016175313A Expired - Fee Related JP6530732B2 (ja) | 2006-03-24 | 2016-09-08 | 造血性幹細胞の増殖を調節する方法 |
| JP2019027038A Expired - Fee Related JP6797222B2 (ja) | 2006-03-24 | 2019-02-19 | 造血性幹細胞の増殖を調節する方法 |
| JP2019171346A Withdrawn JP2019214620A (ja) | 2006-03-24 | 2019-09-20 | 造血性幹細胞の増殖を調節する方法 |
| JP2021170835A Pending JP2022025091A (ja) | 2006-03-24 | 2021-10-19 | 造血性幹細胞の増殖を調節する方法 |
| JP2023098876A Pending JP2023112027A (ja) | 2006-03-24 | 2023-06-16 | 造血性幹細胞の増殖を調節する方法 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009501606A Active JP5247675B2 (ja) | 2006-03-24 | 2007-03-26 | 造血性幹細胞の増殖を調節する方法 |
| JP2013046473A Expired - Fee Related JP6041711B2 (ja) | 2006-03-24 | 2013-03-08 | 造血性幹細胞の増殖を調節する方法 |
| JP2015147317A Active JP6208719B2 (ja) | 2006-03-24 | 2015-07-27 | 造血性幹細胞の増殖を調節する方法 |
| JP2016175313A Expired - Fee Related JP6530732B2 (ja) | 2006-03-24 | 2016-09-08 | 造血性幹細胞の増殖を調節する方法 |
| JP2019027038A Expired - Fee Related JP6797222B2 (ja) | 2006-03-24 | 2019-02-19 | 造血性幹細胞の増殖を調節する方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021170835A Pending JP2022025091A (ja) | 2006-03-24 | 2021-10-19 | 造血性幹細胞の増殖を調節する方法 |
| JP2023098876A Pending JP2023112027A (ja) | 2006-03-24 | 2023-06-16 | 造血性幹細胞の増殖を調節する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (7) | US8168428B2 (enExample) |
| EP (3) | EP2423303A1 (enExample) |
| JP (8) | JP5247675B2 (enExample) |
| CN (2) | CN102626517B (enExample) |
| AU (1) | AU2007230902B2 (enExample) |
| CA (1) | CA2647201C (enExample) |
| MX (3) | MX373998B (enExample) |
| RU (2) | RU2425876C2 (enExample) |
| WO (1) | WO2007112084A2 (enExample) |
| ZA (2) | ZA200808123B (enExample) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX373998B (es) | 2006-03-24 | 2020-07-22 | Childrens Medical Center | Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc. |
| JP5426389B2 (ja) | 2006-10-20 | 2014-02-26 | チルドレンズ メディカル センター コーポレーション | 組織の再生を亢進するための方法 |
| WO2008073748A1 (en) * | 2006-12-08 | 2008-06-19 | University Of Rochester | Expansion of hematopoietic stem cells |
| US8263403B2 (en) * | 2007-04-23 | 2012-09-11 | Stowers Institute For Medical Research | Methods and compositions for stem cell self-renewal |
| US8871752B2 (en) * | 2008-02-19 | 2014-10-28 | Sucampo Ag | Method for modulating stem cell growth |
| ITUD20080058A1 (it) | 2008-03-18 | 2009-09-19 | Thankstem S R L | Kit per la raccolta di sangue, preferibilmente periferico, per la produzione di cellule staminali |
| US20110206781A1 (en) * | 2008-05-28 | 2011-08-25 | Zon Leonard I | Method to modulate hematopoietic stem cell growth |
| CN107523587A (zh) | 2008-11-06 | 2017-12-29 | 印第安纳大学研究与技术公司 | 增强造血干细胞植入过程的材料和方法 |
| WO2010091052A2 (en) | 2009-02-03 | 2010-08-12 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| WO2010096264A2 (en) | 2009-02-03 | 2010-08-26 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| US20120202288A1 (en) * | 2009-03-19 | 2012-08-09 | Fate Therapeutics, Inc. | Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same |
| US20120195862A1 (en) * | 2009-04-17 | 2012-08-02 | Children's Medical Center Corporation | Biomechanical induction of hematopoiesis |
| EP2251010A1 (en) | 2009-05-08 | 2010-11-17 | Sygnis Bioscience GmbH & Co. KG | Use of thiabendazole and derivatives thereof for the therapy of neurological conditions |
| JP6037836B2 (ja) * | 2009-11-15 | 2016-12-07 | インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション | 特異的プロスタグランジンｅ２受容体の特定を含む幹細胞の送達及び生着を高めるための方法 |
| US20130129686A1 (en) * | 2009-11-19 | 2013-05-23 | Regents Of The University | Reducing Inflammation Using Cell Therapy |
| WO2011143125A2 (en) * | 2010-05-10 | 2011-11-17 | Fate Therapeutics, Inc. | Biovessels |
| CN112501118A (zh) * | 2010-08-12 | 2021-03-16 | 菲特治疗公司 | 改进的造血干细胞和祖细胞疗法 |
| DK2663313T3 (en) * | 2011-01-13 | 2018-11-26 | Scipharm S A R L | PROCEDURE FOR IMPROVING ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS |
| EP2701694A4 (en) * | 2011-04-28 | 2014-10-08 | Univ Duke | METHOD FOR THE TREATMENT OF HEMOGLOBINOPATHIES |
| CN108220246B (zh) | 2011-09-30 | 2022-07-12 | 蓝鸟生物公司 | 用于改善病毒转导的化合物 |
| ES2682255T3 (es) | 2011-12-02 | 2018-09-19 | Fate Therapeutics, Inc. | Métodos mejorados de tratamiento de isquemia |
| PT2785834T (pt) | 2011-12-02 | 2020-11-13 | Fate Therapeutics Inc | Composição de células estaminais melhorada |
| WO2013086029A1 (en) | 2011-12-05 | 2013-06-13 | Primorigen Biosciences Inc. | Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof |
| WO2014015318A1 (en) * | 2012-07-19 | 2014-01-23 | Bluebird Bio, Inc. | Soluble compounds for improved gene therapy methods |
| WO2014081760A1 (en) | 2012-11-20 | 2014-05-30 | Duke University | Methods of treating hemoglobinopathies |
| US9943545B2 (en) | 2013-03-15 | 2018-04-17 | Fate Therapeutics, Inc. | Stem cell culture media and methods of enhancing cell survival |
| EP2968416A4 (en) | 2013-03-15 | 2016-08-17 | Fate Therapeutics Inc | CELL POTENTIAL TEST FOR THERAPEUTIC POTENTIAL |
| US9428748B2 (en) * | 2013-06-17 | 2016-08-30 | Hong Gao | Method of expanding hematopoietic stem cells |
| JP2015205835A (ja) * | 2014-04-21 | 2015-11-19 | 国立大学法人福井大学 | 中性子線障害防護剤 |
| EP3134096A4 (en) * | 2014-04-23 | 2018-01-10 | Texas Heart Institute | Methods of enhancing stem cell engraftment |
| US9816074B2 (en) | 2014-07-25 | 2017-11-14 | Sangamo Therapeutics, Inc. | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells |
| US10435677B2 (en) | 2014-09-16 | 2019-10-08 | Sangamo Therapeutics, Inc. | Genetically modified human cell with a corrected mutant sickle cell mutation |
| JP6800859B2 (ja) | 2015-01-26 | 2020-12-16 | フェイト セラピューティクス，インコーポレイテッド | 造血細胞分化を誘導するための方法および組成物 |
| EP3313420B1 (en) | 2015-06-25 | 2024-03-13 | The Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| AU2016296741A1 (en) | 2015-07-21 | 2018-02-22 | The Children's Medical Center Corporation | PD-L1 expressing hematopoietic stem cells and uses |
| CN105296427A (zh) * | 2015-10-23 | 2016-02-03 | 深圳爱生再生医学科技有限公司 | 造血干细胞的体外扩增培养方法 |
| WO2017073692A1 (ja) * | 2015-10-30 | 2017-05-04 | 国立大学法人鳥取大学 | メチル化関連酵素ｈａｔ１とｋａｔ８の阻害薬 |
| JP7534070B2 (ja) | 2015-11-04 | 2024-08-14 | フェイト セラピューティクス，インコーポレイテッド | 造血細胞分化を誘導するための方法および組成物 |
| CN115806940A (zh) | 2015-11-04 | 2023-03-17 | 菲特治疗公司 | 多能细胞的基因组工程改造 |
| BR112018016450A2 (pt) | 2016-02-12 | 2018-12-26 | Bluebird Bio Inc | composições intensificadoras de vcn e métodos de uso das mesmas |
| WO2017139561A1 (en) | 2016-02-12 | 2017-08-17 | Bluebird Bio, Inc. | Vcn enhancer compositions and methods of using the same |
| CA3014667A1 (en) * | 2016-03-04 | 2017-09-08 | The Board Of Trustees Of Leland Stanford Junior University | Compositions and methods for muscle regeneration using prostaglandin e2 |
| US9918994B2 (en) | 2016-03-04 | 2018-03-20 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for muscle regeneration using prostaglandin E2 |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| US11229662B2 (en) | 2016-11-15 | 2022-01-25 | The Schepens Eye Research Institute, Inc. | Compositions and methods for the treatment of aberrant angiogenesis |
| TWI719315B (zh) * | 2017-06-07 | 2021-02-21 | 中央研究院 | 移除未分化的萬能性幹細胞之方法 |
| CN111212648B (zh) | 2017-06-09 | 2024-07-09 | 莱兰斯坦福初级大学评议会 | 用于预防或治疗肌肉疾患的组合物和方法 |
| EP3672590B1 (en) * | 2017-08-22 | 2025-02-12 | The Children's Medical Center Corporation | Methods for inducing hematopoietic stem cell specificity |
| US11879137B2 (en) | 2017-09-22 | 2024-01-23 | The Children's Medical Center Corporation | Treatment of type 1 diabetes and autoimmune diseases or disorders |
| JP7416700B2 (ja) | 2017-11-14 | 2024-01-17 | ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド | 増殖性硝子体網膜症および上皮間葉転換と関連付けられる状態の治療のためのｒｕｎｘ１阻害の方法 |
| EP3597211A1 (en) | 2018-07-19 | 2020-01-22 | Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus | Periostin compounds for the treatment of haematological complications |
| CN109609455A (zh) * | 2018-12-28 | 2019-04-12 | 诺未科技（北京）有限公司 | 扩增造血干细胞的培养体系、方法及其用途 |
| US20220127576A1 (en) * | 2019-02-13 | 2022-04-28 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for stem cell therapy |
| CN110051839A (zh) * | 2019-04-16 | 2019-07-26 | 诺航生物技术(徐州)有限公司 | 一种促进脐带血干细胞体外扩增和增强脐带血干细胞移植后造血重建功能的药物 |
| FI130749B1 (en) * | 2020-01-24 | 2024-02-26 | Faron Pharmaceuticals Oy | USE OF VAP-1 INHIBITOR IN THE EX VIVO CULTURE OF HEMATOPOEITIC STEM CELLS AND IN THE TREATMENT OF BONE Marrow Loss or BONE Marrow Dysfunction |
| EP4146797A1 (en) | 2020-05-06 | 2023-03-15 | Orchard Therapeutics (Europe) Limited | Treatment for neurodegenerative diseases |
| US11883436B2 (en) | 2020-08-17 | 2024-01-30 | The Board Of Trustees Of The University Of Illinois | Method of preparing hematopoietic stem and progenitor cells for transplantation |
| AU2021202658A1 (en) | 2021-04-28 | 2022-11-17 | Fondazione Telethon | Gene therapy |
| GB202206346D0 (en) | 2022-04-29 | 2022-06-15 | Ospedale San Raffaele Srl | Gene therapy |
| KR20240136869A (ko) | 2023-03-07 | 2024-09-19 | 인제대학교 산학협력단 | 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법 |
| US20250332260A1 (en) | 2024-04-10 | 2025-10-30 | Garuda Therapeutics, Inc. | Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA103846A (en) | 1906-12-03 | 1907-02-26 | William Bell | Manufacture of half-tone printing blocks |
| US3217903A (en) | 1961-01-19 | 1965-11-16 | Mc Graw Edison Co | Segregating control |
| US3753357A (en) | 1970-12-14 | 1973-08-21 | Ovitron Res Corp | Method and apparatus for the preservation of cells and tissues |
| US4199022A (en) | 1978-12-08 | 1980-04-22 | The United States Of America As Represented By The Department Of Energy | Method of freezing living cells and tissues with improved subsequent survival |
| US4239679A (en) | 1979-06-27 | 1980-12-16 | Diamond Shamrock Corporation | High bulk density rigid poly(vinyl chloride) resin powder composition and preparation thereof |
| HU181154B (en) | 1980-07-18 | 1983-06-28 | Epitestudomanyi Intezet | Shaped building unit and space limiting or dividing structure made of same as well as method for producing the shaped building unit |
| US4559298A (en) | 1982-11-23 | 1985-12-17 | American National Red Cross | Cryopreservation of biological materials in a non-frozen or vitreous state |
| US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| SG59931A1 (en) * | 1989-10-16 | 1999-02-22 | Amgen Inc | Stem cell factor |
| US5114672A (en) | 1990-08-27 | 1992-05-19 | Cryo-Cell International, Inc. | Method for preserving blood fluid |
| AU702871B2 (en) * | 1993-08-23 | 1999-03-11 | Nexell Therapeutics Inc. | (In vitro) growth of neutrophil and megakaryocyte precursors in serum-free media |
| AU6125396A (en) * | 1995-06-07 | 1996-12-30 | Novartis Ag | Serum-free media for primitive hematopoietic cells and metho ds of use thereof |
| US6372796B1 (en) | 1996-11-13 | 2002-04-16 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
| GB9904281D0 (en) * | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
| RU2259830C2 (ru) | 1999-11-24 | 2005-09-10 | Оно Фармасьютикал Ко., Лтд. | Фармацевтическая композиция для лечения заболеваний, связанных с потерей костной массы |
| TWI247606B (en) | 1999-11-24 | 2006-01-21 | Ono Pharmaceutical Co | Treating agent for osteopenic diseases |
| US6226997B1 (en) | 1999-12-07 | 2001-05-08 | Cryo-Cell International, Inc. | Method and device for maintaining temperature integrity of cryogenically preserved biological samples |
| US6852534B2 (en) | 2000-11-03 | 2005-02-08 | Kourion Therapeutics Gmbh | Method to determine an engrafting cell dose of hematopoietic stem cell transplant units |
| JP4077158B2 (ja) | 2001-01-10 | 2008-04-16 | 株式会社メニコン | 植物性繊維分解剤およびそれを用いた植物性廃棄物の処理法 |
| MXPA03007175A (es) | 2001-02-14 | 2005-02-14 | Anthrogenesis Corp | Placenta de mamiferos postparto, su uso y celulas madres placentales extraidas de ella. |
| FR2825261B1 (fr) | 2001-06-01 | 2003-09-12 | Maco Pharma Sa | Ligne de prelevement du sang placentaire comprenant une poche de rincage |
| US7179643B2 (en) | 2001-06-14 | 2007-02-20 | Reliance Life Sciences Pvt. Ltd. | Device and a process for expansion of haemopoeitic stem cells for therapeutic use |
| WO2003042405A2 (en) | 2001-11-15 | 2003-05-22 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
| WO2003055989A2 (en) * | 2001-12-21 | 2003-07-10 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
| RU2205627C1 (ru) * | 2002-05-30 | 2003-06-10 | Открытое акционерное общество "Косметическое объединение "Свобода" | Крем для лица, выводящий токсины |
| JP4497320B2 (ja) | 2002-10-10 | 2010-07-07 | 小野薬品工業株式会社 | 内因性修復因子産生促進剤 |
| WO2004078169A1 (en) | 2003-03-04 | 2004-09-16 | Pfizer Products Inc. | Use of ep2 selective receptor agonists in medical treatment |
| US20050054103A1 (en) * | 2003-03-07 | 2005-03-10 | Tony Peled | Expansion of renewable stem cell populations using modulators of PI 3-kinase |
| EP1613742A2 (en) | 2003-04-08 | 2006-01-11 | YEDA RESEARCH AND DEVELOPMENT Co. LTD. | Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| GB0324523D0 (en) | 2003-10-21 | 2003-11-26 | Medical Res Council | Compositions and methods of treatment |
| US8309608B2 (en) | 2003-11-06 | 2012-11-13 | Sanofi-Aventis Deutschland Gmbh | Use of eNOS transcription enhancers in the cell therapy of ischemic heart diseases |
| IL158868A0 (en) | 2003-11-13 | 2004-05-12 | Yeda Res & Dev | Methods of generating and using stem cells enriched with immature primitive progenitor |
| WO2006005153A1 (en) * | 2004-07-09 | 2006-01-19 | Bc Cancer Agency | Nup98-hox fusions for expansion of hemopoietic stem cells |
| US7147626B2 (en) | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
| WO2006078886A2 (en) | 2005-01-18 | 2006-07-27 | Irm Llc | Compounds and compositions as wnt signaling pathway modulators |
| CA2597757C (en) | 2005-02-10 | 2016-06-28 | Regents Of The University Of Minnesota | Vascular/lymphatic endothelial cells |
| WO2007117262A2 (en) | 2005-07-29 | 2007-10-18 | Athersys, Inc. | Culture of non-embryonic cells at high cell density |
| JP4562618B2 (ja) | 2005-08-18 | 2010-10-13 | 陽一 佐藤 | 空き缶処理車 |
| US8318489B2 (en) * | 2005-12-22 | 2012-11-27 | Bruce Paul Davidson | Prostacyclin directed differentiation of cardiomyocytes from human embryonic stem cells |
| MX373998B (es) | 2006-03-24 | 2020-07-22 | Childrens Medical Center | Uso de un modulador de células madre hematopoyeticas (hsc) para promover el crecimiento de hsc. |
| US8241903B2 (en) | 2006-06-22 | 2012-08-14 | Yeda Research And Development Co., Ltd. | Catecholamine receptor modulation |
| WO2008021475A2 (en) | 2006-08-16 | 2008-02-21 | The General Hospital Corporation | Compositions and methods for hematopoietic stem cell expansion or for modulating angiogenesis |
| KR20080042761A (ko) | 2006-11-10 | 2008-05-15 | 문찬일 | 렙틴을 이용한 줄기세포 증식방법 |
| WO2008073748A1 (en) * | 2006-12-08 | 2008-06-19 | University Of Rochester | Expansion of hematopoietic stem cells |
-
2007
- 2007-03-26 MX MX2015007504A patent/MX373998B/es unknown
- 2007-03-26 RU RU2008142106A patent/RU2425876C2/ru active
- 2007-03-26 AU AU2007230902A patent/AU2007230902B2/en not_active Ceased
- 2007-03-26 EP EP20110004943 patent/EP2423303A1/en not_active Withdrawn
- 2007-03-26 CN CN201210050521.9A patent/CN102626517B/zh active Active
- 2007-03-26 EP EP07773772A patent/EP1999255A2/en not_active Withdrawn
- 2007-03-26 ZA ZA200808123A patent/ZA200808123B/xx unknown
- 2007-03-26 MX MX2008012178A patent/MX2008012178A/es active IP Right Grant
- 2007-03-26 CN CN200780018870XA patent/CN101495623B/zh active Active
- 2007-03-26 RU RU2011115827/10A patent/RU2493252C2/ru active
- 2007-03-26 WO PCT/US2007/007419 patent/WO2007112084A2/en not_active Ceased
- 2007-03-26 EP EP18175819.4A patent/EP3424507A1/en not_active Withdrawn
- 2007-03-26 CA CA2647201A patent/CA2647201C/en active Active
- 2007-03-26 JP JP2009501606A patent/JP5247675B2/ja active Active
- 2007-04-26 US US12/294,344 patent/US8168428B2/en not_active Expired - Fee Related
-
2008
- 2008-09-23 MX MX2019007494A patent/MX2019007494A/es unknown
-
2009
- 2009-09-21 ZA ZA200906574A patent/ZA200906574B/xx unknown
-
2012
- 2012-03-27 US US13/431,534 patent/US8551782B2/en not_active Expired - Fee Related
- 2012-03-27 US US13/431,563 patent/US9028811B2/en active Active
- 2012-03-27 US US13/431,499 patent/US8563310B2/en not_active Expired - Fee Related
-
2013
- 2013-03-08 JP JP2013046473A patent/JP6041711B2/ja not_active Expired - Fee Related
- 2013-03-15 US US13/837,265 patent/US20130209424A1/en not_active Abandoned
- 2013-03-15 US US13/836,794 patent/US10278990B2/en active Active
- 2013-03-15 US US13/838,002 patent/US10272110B2/en active Active
-
2015
- 2015-07-27 JP JP2015147317A patent/JP6208719B2/ja active Active
-
2016
- 2016-09-08 JP JP2016175313A patent/JP6530732B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-19 JP JP2019027038A patent/JP6797222B2/ja not_active Expired - Fee Related
- 2019-09-20 JP JP2019171346A patent/JP2019214620A/ja not_active Withdrawn
-
2021
- 2021-10-19 JP JP2021170835A patent/JP2022025091A/ja active Pending
-
2023
- 2023-06-16 JP JP2023098876A patent/JP2023112027A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019214620A5 (enExample) | ||
| JP2022025091A5 (enExample) | ||
| Kasbekar et al. | Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands | |
| Batsivari et al. | Dynamic responses of the haematopoietic stem cell niche to diverse stresses | |
| JP2013523841A5 (enExample) | ||
| NZ728022A (en) | Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors | |
| CN104082277A (zh) | 一种人外周血单个核细胞的冻存保护剂及保存方法 | |
| BR112018072701A2 (pt) | métodos de tratamento de leucemia mieloide aguda e mieloma múltiplo usando células exterminadoras naturais | |
| Richter et al. | Local exchange of metabolites shapes immunity | |
| CN112135618A (zh) | 体内介导免疫应答的nk和dc细胞的扩增 | |
| JP2015517520A5 (enExample) | ||
| Stanevsky et al. | Double umbilical cord blood transplant: more than a cell dose? | |
| BR112021021349A2 (pt) | Métodos de fabricação de células car t alogênicas | |
| JP2009517078A5 (enExample) | ||
| JP2018537440A5 (enExample) | ||
| Demirci et al. | Ex vivo culture resting time impacts transplantation outcomes of genome-edited human hematopoietic stem and progenitor cells in xenograft mouse models | |
| Hung | Effects of hypoxic culture on bone marrow mesenchymal stem cells: from bench to bedside | |
| MX2021013227A (es) | Expansion ex-vivo sin microesferas de celulas t reguladoras humanas. | |
| Kakavoulia | Overview of very small embryonic like stem cells (VSELs) and their therapeutic potential | |
| Ishaq et al. | Stem Cells Storage, Packaging, and Transportation | |
| Trufanova et al. | Bioengineering of MSC-based 3D constructs with different types of cell organization | |
| Bassani et al. | CD40 provides immune privilege to the bone marrow hematopoietic niche | |
| JPWO2020124248A5 (enExample) | ||
| Maalaoui | Characterization of the UM171-Graft: Dissecting the lymphoid lineage potential of the UM171-Graft | |
| Theocharidis | Characterising the metabolic reprogramming of human alloreactive T cells |